Miller Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.52M Buy
3,907
+2
+0.1% +$2.36K 1.88% 11
2026
Q2
$4.68M Buy
3,905
+27
+0.7% +$27.6K 1.82% 9
2026
Q1
$3.57M Buy
3,878
+47
+1% +$47.6K 1.71% 12
2025
Q4
$4.12M Hold
3,831
– – 2.07% 9

Other funds holding LLY

Miller Capital Partners's LLY Position: Q3 2026 in Review

Miller Capital Partners increased its Eli Lilly (LLY) stake by 0.05% in Q3 2026, buying an estimated $2.36K and bringing the position to 3,907 shares worth $4.52M. The position accounts for 1.88% of the portfolio, ranked #11.

Miller Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.68M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Miller Capital Partners held 3,907 shares of Eli Lilly worth $4.52M as of Q3 2026.
  • Miller Capital Partners bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 1.88% of Miller Capital Partners's portfolio in Q3 2026, its #11 holding.
  • Miller Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Miller Capital Partners's Eli Lilly position peaked at $4.68M in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Miller Capital Partners's 13F filing for Q3 2026, filed 12 Nov 2026.